Syschem India Ltd Stock Price Today (NSE: SYSCHEM)
Fundamental Score
Syschem India Ltd Share Price — Live NSE/BSE Price, Fundamentals & Analysis
Syschem India Ltd share price today is ₹47.39, up +1.26% on NSE/BSE as of 19 June 2026. Syschem India Ltd (SYSCHEM) is a Small-cap company in the Pharmaceuticals sector with a market capitalisation of ₹237.63 (Cr). The 52-week high for SYSCHEM share price is ₹62.00 and the 52-week low is ₹40.50. At a P/E ratio of 52.46x, SYSCHEM is currently trading above its industry average P/E of 31.77x. The company has a Return on Equity (ROE) of 0.62% and a debt-to-equity ratio of 0.00.
Syschem India Ltd Share Price Chart — NSE/BSE Historical Performance
Syschem India Ltd share price chart: -2.56% return over the past month. 52-week high ₹62.00, 52-week low ₹40.50.
Syschem India Ltd — Last 10 Trading Days
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| ₹47.49 | ₹48.40 | ₹46.85 | ₹47.39 | 8.34K (Cr) | |
| ₹47.24 | ₹48.50 | ₹46.50 | ₹46.80 | 25.19K (Cr) | |
| ₹49.82 | ₹49.82 | ₹46.35 | ₹46.99 | 62.54K (Cr) | |
| ₹51.41 | ₹51.87 | ₹48.16 | ₹49.83 | 32.48K (Cr) | |
| ₹52.80 | ₹52.80 | ₹49.00 | ₹50.45 | 1.12L (Cr) | |
| ₹53.25 | ₹53.25 | ₹49.00 | ₹49.39 | 1.49L (Cr) | |
| ₹51.41 | ₹51.79 | ₹51.00 | ₹51.05 | 26.92K (Cr) | |
| ₹51.49 | ₹51.73 | ₹50.00 | ₹51.12 | 15.12K (Cr) | |
| ₹50.98 | ₹50.98 | ₹49.03 | ₹50.49 | 13.54K (Cr) | |
| ₹49.90 | ₹50.00 | ₹48.20 | ₹49.50 | 20.33K (Cr) |
Syschem India Ltd — Last 12 Months Price History
| Month | Open | High | Low | Close | Change |
|---|---|---|---|---|---|
| ₹47.24 | ₹48.50 | ₹46.50 | ₹47.39 | +0.32% | |
| ₹51.78 | ₹54.71 | ₹46.35 | ₹46.99 | -9.25% | |
| ₹43.60 | ₹54.90 | ₹43.01 | ₹51.78 | +18.76% | |
| ₹48.20 | ₹49.80 | ₹40.50 | ₹41.32 | -14.27% | |
| ₹51.70 | ₹57.80 | ₹45.10 | ₹48.59 | -6.02% | |
| ₹47.50 | ₹55.97 | ₹44.00 | ₹46.87 | -1.33% | |
| ₹56.19 | ₹56.19 | ₹45.63 | ₹46.75 | -16.80% | |
| ₹54.00 | ₹60.95 | ₹52.00 | ₹54.36 | +0.67% | |
| ₹55.00 | ₹59.45 | ₹53.80 | ₹54.30 | -1.27% | |
| ₹57.35 | ₹61.49 | ₹52.50 | ₹55.27 | -3.63% | |
| ₹44.00 | ₹62.00 | ₹43.80 | ₹57.32 | +30.27% | |
| ₹46.51 | ₹48.50 | ₹43.50 | ₹44.52 | -4.28% |
Returns & Performance
Return on Equity (ROE)
Profit generated per ₹1 of shareholder equity
Return on Capital (ROCE)
Returns generated on total capital deployed
Oper. Profit Margin (5Y Avg)
Average operating profit margin over 5 years
Dividend Yield
Annual dividend as % of current share price
Syschem India Ltd Valuation Check
Price to Earnings (P/E)
Share price ÷ earnings per share. Lower = cheaper
Industry Avg P/E
Average P/E of all peers in this sector
Market Capitalisation
Total market value of all outstanding shares
Growth Engine
Profit Growth (Quarterly YoY)
Net profit growth vs same quarter last year
Revenue Growth (Quarterly YoY)
Revenue growth vs same quarter last year
Revenue Growth (5-Year CAGR)
Compounded annual revenue growth over 5 years
EPS Growth (5-Year CAGR)
Earnings per share growth over 5 years
Net Profit Growth (5-Year CAGR)
Compounded annual net profit growth over 5 years
Balance Sheet Health
Debt to Equity Ratio
Total debt ÷ equity. Below 0.5 = financially healthy
Interest Coverage Ratio
EBIT ÷ interest expense. Above 2.5 = can pay interest comfortably
Free Cash Flow (5-Year Total)
Cash left after capex over 5 years. Positive = self-funded growth
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Syschem India Ltd Fundamental Analysis & Valuation Benchmarking
Educational evaluation of SYSCHEM across key market metrics for learning purposes.
Positive Indicators
9 factors identified
Robust Profit Growth (396.88%)
Observation: Strong year-over-year profit expansion demonstrates business momentum.
Analysis: Profit growth >20% indicates effective execution and market opportunity capture.
Strong Revenue Growth (118.01%)
Observation: Healthy sales growth indicates market demand and execution capability.
Analysis: Revenue growth >15% suggests strong market position and growth potential.
Consistent Growth Track Record (33.94% CAGR)
Observation: Strong 5-year sales compound annual growth rate.
Analysis: Consistent sales CAGR >12% demonstrates sustainable growth model.
Excellent EPS Growth (16.40% CAGR)
Observation: Outstanding 5-year earnings per share compound growth.
Analysis: EPS CAGR >15% indicates strong wealth creation potential.
Strong Profit Growth Track Record (17.64% CAGR)
Observation: Consistent 5-year profit compound annual growth rate.
Analysis: Profit CAGR >15% demonstrates scalable business model.
Debt-Free Balance Sheet (D/E: 0.00)
Observation: Low leverage provides financial flexibility and reduced risk.
Analysis: Conservative debt structure offers resilience during economic downturns.
Strong Interest Coverage (64.56x)
Observation: Earnings comfortably cover interest obligations.
Analysis: Interest coverage >5x indicates low financial distress risk.
Balanced Promoter Holding (56.71%)
Observation: Optimal balance between promoter control and public float.
Analysis: Promoter holding in 50-75% range provides management alignment.
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral.
Analysis: Absence of share pledging eliminates potential forced-selling pressure.
Risk Factors
7 factors identified
Below-Average Return on Equity (0.62%)
Observation: Returns on equity are below industry benchmarks.
Analysis: ROE <10% may indicate inefficient capital utilization. Consider monitoring for operational improvements and management effectiveness.
Suboptimal ROCE (1.47%)
Observation: Returns on capital employed are below expectations.
Analysis: ROCE <10% suggests potential inefficiencies in capital allocation.
Margin Pressure Concerns (1.98%)
Observation: Operating margins are below industry standards.
Analysis: OPM <5% may indicate pricing pressures or cost management challenges.
Premium Valuation Risk (P/E: 52.46x)
Observation: High valuation multiples may limit upside potential.
Analysis: Elevated P/E ratios require strong growth execution to justify current valuations.
Negative Free Cash Flow (₹-78.30 Cr over 5Y)
Observation: Cash outflows exceed inflows.
Analysis: Negative FCF requires analysis of capital expenditure cycle.
Limited Institutional Interest (FII+DII: 0.18%)
Observation: Low institutional participation may affect liquidity.
Analysis: Limited institutional interest may indicate size constraints or visibility issues.
No Dividend Distribution
Observation: Company does not currently pay dividends to shareholders.
Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints.
Syschem India Ltd vs Pharmaceuticals Peers
Peer Comparison - Pharmaceuticals
Compare Syschem India Ltd with 10 other companies in the same sector
| Company Info | Fundamental | Valuation | Profitability | Financial Health | Growth | Dividend | ||||
|---|---|---|---|---|---|---|---|---|---|---|
Company Company name | Score Bull Run comprehensive fundamental score based on 20+ metrics | Price Current trading price of the stock | Market Cap Total value of all shares in the market | P/E Price per share divided by earnings per share | ROE Net income divided by shareholder equity | ROCE Earnings before interest and tax divided by capital employed | Debt/Eq Total debt divided by total equity | Profit 5Y Average annual profit growth over 5 years | Sales 5Y Average annual sales growth over 5 years | Dividend Annual dividend per share divided by price per share |
Syschem India LtdSyschem India L...Selected✓ SYSCHEM • 531173 | 58.4/100 | ₹47.39₹47 | ₹237.63₹237.63 | 52.46Average 52.5 Average | 0.62%Poor 0.62% Poor | 1.47%Poor 1.47% Poor | 0.00Excellent 0.0 Excellent | 17.64%Excellent 17.64% Excellent | 33.94%Excellent 33.94% Excellent | 0.00% |
Sun Pharmaceutical Industries LtdSun Pharmaceuti... SUNPHARMA • 524715 | 65.2/100 | ₹1844.30₹1844 | ₹433738.68₹433738.68 | 37.57Average 37.6 Average | 16.86%Good 16.86% Good | 20.21%Excellent 20.21% Excellent | 0.07Excellent 0.1 Excellent | 23.78%Excellent 23.78% Excellent | 9.87%Good 9.87% Good | 0.89% |
Divis Laboratories LtdDivis Laborator... DIVISLAB • 532488 | 67.9/100 | ₹6797.50₹6798 | ₹170445.88₹170445.88 | 68.59Average 68.6 Average | 15.35%Good 15.35% Good | 20.44%Excellent 20.44% Excellent | 0.01Excellent 0.0 Excellent | 10.41%Good 10.41% Good | 11.65%Good 11.65% Good | 0.47% |
Torrent Pharmaceuticals LtdTorrent Pharmac... TORNTPHARM • 500420 | 65.3/100 | ₹4537.80₹4538 | ₹126430.62₹126430.62 | 58.36Average 58.4 Average | 26.52%Excellent 26.52% Excellent | 27.05%Excellent 27.05% Excellent | 0.33Excellent 0.3 Excellent | 13.84%Good 13.84% Good | 7.72%Good 7.72% Good | 0.86% |
Cipla LtdCipla Ltd... CIPLA • 500087 | 59/100 | ₹1418.20₹1418 | ₹123059.76₹123059.76 | 22.62Average 22.6 Average | 17.77%Good 17.77% Good | 22.72%Excellent 22.72% Excellent | 0.01Excellent 0.0 Excellent | 28.68%Excellent 28.68% Excellent | 9.97%Good 9.97% Good | 0.85% |
Dr Reddys Laboratories LtdDr Reddys Labor... DRREDDY • 500124 | 59.2/100 | ₹1319.00₹1319 | ₹105224.96₹105224.96 | 18.23Average 18.2 Average | 17.96%Good 17.96% Good | 22.69%Excellent 22.69% Excellent | 0.16Excellent 0.2 Excellent | 22.28%Excellent 22.28% Excellent | 13.26%Good 13.26% Good | 0.63% |
Lupin LtdLupin Ltd... LUPIN • 500257 | 66.7/100 | ₹2276.40₹2276 | ₹95148.15₹95148.15 | 22.00Average 22.0 Average | 20.62%Excellent 20.62% Excellent | 21.30%Excellent 21.30% Excellent | 0.32Excellent 0.3 Excellent | 54.88%Excellent 54.88% Excellent | 8.11%Good 8.11% Good | 0.58% |
Zydus Lifesciences LtdZydus Lifescien... ZYDUSLIFE • 532321 | 68.7/100 | ₹956.95₹957 | ₹94253.78₹94253.78 | 18.74Average 18.7 Average | 21.21%Excellent 21.21% Excellent | 24.31%Excellent 24.31% Excellent | 0.38Excellent 0.4 Excellent | 25.92%Excellent 25.92% Excellent | 10.27%Good 10.27% Good | 1.17% |
Mankind Pharma LtdMankind Pharma ... MANKIND • 543904 | 50.6/100 | ₹2420.40₹2420 | ₹92012.53₹92012.53 | 52.62Average 52.6 Average | 14.68%Average 14.68% Average | 15.98%Good 15.98% Good | 0.55Good 0.6 Good | 11.73%Good 11.73% Good | 15.79%Excellent 15.79% Excellent | 0.04% |
Aurobindo Pharma LtdAurobindo Pharm... AUROPHARMA • 524804 | 28.8/100 | ₹1435.90₹1436 | ₹70798.69₹70798.69 | 20.69Average 20.7 Average | 11.08%Average 11.08% Average | 14.18%Average 14.18% Average | 0.22Excellent 0.2 Excellent | 3.87%Average 3.87% Average | 6.55%Good 6.55% Good | 0.33% |
Alkem Laboratories LtdAlkem Laborator... ALKEM • 539523 | 59.5/100 | ₹5451.50₹5452 | ₹67075.29₹67075.29 | 28.54Average 28.5 Average | 19.39%Good 19.39% Good | 20.38%Excellent 20.38% Excellent | 0.18Excellent 0.2 Excellent | 13.93%Good 13.93% Good | 9.21%Good 9.21% Good | 0.80% |
Top Pharmaceuticals Stocks
View all →By Bull Run Score
By Return on Equity
By Market Cap
- Sun Pharmaceutical Industries Ltd share price433738.68 Cr
- Divis Laboratories Ltd share price170445.88 Cr
- Torrent Pharmaceuticals Ltd share price126430.62 Cr
- Cipla Ltd share price123059.76 Cr
- Dr Reddys Laboratories Ltd share price105224.96 Cr
Syschem India Ltd PE Ratio History
Historical price-to-earnings ratio for SYSCHEM — last 5 years
| Year | EPS (₹) | Price (₹) | P/E Ratio |
|---|---|---|---|
| FY 2025 | ₹0.12 | ₹46.75 | 406.5x |
| FY 2024 | ₹0.78 | ₹49.81 | 63.9x |
P/E = year-end price ÷ diluted EPS from annual filings. Source: NSE/BSE via Bull Run.
Syschem India Ltd Quarterly Performance
Latest quarterly metrics for SYSCHEM — revenue growth and profit growth vs same quarter last year
Revenue Growth (YoY)
118.01%
Latest quarter vs same quarter previous year
Net Profit Growth (YoY)
396.88%
Latest quarter net profit vs same quarter previous year
5-Year Revenue CAGR
33.94%
Compounded annual revenue growth over 5 years
5-Year Profit CAGR
17.64%
Compounded annual net profit growth over 5 years
Syschem India Ltd Technical Indicators
SMA 50, SMA 200, RSI and volume signals for SYSCHEM — calculated from daily price history
Momentum is balanced — neither overbought nor oversold.
Technical indicators are for educational purposes only. Not investment advice.
Syschem India Ltd Financial Statements
Annual income statement, balance sheet and cash flow for Syschem India Ltd (SYSCHEM) — sourced from NSE/BSE filings.
Loading Financial Statements...
Fetching financial data for Syschem India Ltd
About SYSCHEM (Syschem India Ltd)
Syschem India Ltd is a dynamic pharmaceutical company committed to advancing healthcare through the development and production of high-quality active pharmaceutical ingredients (AP...Is) and specialized chemical products. With a strong focus on research and innovation, Syschem serves as a trusted partner to pharmaceutical formulators worldwide, providing essential building blocks for a diverse range of medications. The company's state-of-the-art manufacturing facilities adhere to stringent regulatory standards, ensuring the purity, safety, and efficacy of all its offerings. Syschem prides itself on its commitment to sustainable practices, striving to minimize its environmental footprint while delivering exceptional value to its customers. Syschem's diverse product portfolio encompasses a wide spectrum of APIs and intermediates, catering to various therapeutic areas. Core products include a range of beta-lactam antibiotics, crucial in combating bacterial infections. Furthermore, the company specializes in the production of specialty solvents, vital for various pharmaceutical processes, including purification and extraction. Syschem's dedicated research and development team continuously explores new synthetic routes and process improvements to enhance product quality and efficiency. This commitment to innovation allows Syschem to stay at the forefront of the pharmaceutical industry, addressing evolving market needs and delivering cutting-edge solutions. Beyond its core product offerings, Syschem extends its capabilities through contract manufacturing services, providing customized solutions to meet the specific requirements of its clients. This allows pharmaceutical companies to leverage Syschem's expertise and infrastructure to accelerate product development and manufacturing, while maintaining the highest quality standards. Syschem's customer-centric approach, coupled with its unwavering commitment to excellence, has solidified its position as a reliable and trusted partner in the global pharmaceutical landscape, enabling access to life-enhancing medications for patients worldwide.
Company Details
Key Leadership
Latest News
SYSCHEM Share Price: Frequently Asked Questions
What is the current share price of Syschem India Ltd?
Syschem India Ltd (SYSCHEM) trades at ₹47.39 on NSE and BSE. Market cap ₹237.63 (Cr). Educational data only.
What is the P/E ratio of Syschem India Ltd?
Syschem India Ltd has a P/E of 52.46x vs industry average 31.77x.
What is the Bull Run score for Syschem India Ltd?
Syschem India Ltd has a Bull Run score of 58.4/100 based on 25+ financial parameters.
Does Syschem India Ltd pay dividends?
Syschem India Ltd has a dividend yield of 0.00%. Past dividends don't guarantee future payments.
What is the ROE of Syschem India Ltd?
Syschem India Ltd has ROE of 0.62%. Higher ROE indicates better use of shareholder equity.
What is the debt-to-equity ratio of Syschem India Ltd?
Syschem India Ltd has debt-to-equity of 0.00.
Is Syschem India Ltd a good investment?
Bull Run gives Syschem India Ltd a score of 58.4/100. This is not investment advice — consult a SEBI-registered advisor.